Rosenthal EM, Hall EW, Rosenberg ES, Harris A, et al. Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206-8215]. Vaccine 2021 Jul 31. pii: S0264-410X(21)00963.
PMID: 34344554